Page last updated: 2024-09-03

glycyl-arginyl-glycyl-aspartyl-serine and B16 Melanoma

glycyl-arginyl-glycyl-aspartyl-serine has been researched along with B16 Melanoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, L; Liu, M; Liu, Y; Sheng, D; Song, J; Wang, Z; Wu, M; Yang, Z; Yi, H; Zhang, L; Zhang, N; Zheng, Y1
Bastida, E; Bertomeu, MC; Buchanan, MR; Gallo, S; Haas, TA; Lauri, D; Orr, FW1
Kuwashima, N1
Breton, P; Grzegorzewski, K; Nagai, T; Newton, SA; Olden, K; Oredipe, O; White, SL; Yasuda, Y1
Humphries, MJ; Olden, K; Yamada, KM1

Reviews

1 review(s) available for glycyl-arginyl-glycyl-aspartyl-serine and B16 Melanoma

ArticleYear
The use of novel antineoplastic agents to inhibit the growth and metastasis of malignant melanoma and other cancers.
    Pigment cell research, 1992, Volume: Suppl 2

    Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Adhesion; Cell Division; Drug Design; Drug Screening Assays, Antitumor; Extracellular Matrix; Fibronectins; Glycosylation; Indolizines; Lung Neoplasms; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Neoplasm Metastasis; Neoplasm Proteins; Oligopeptides; Oligosaccharides; Protein Processing, Post-Translational; Swainsonine

1992

Other Studies

4 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and B16 Melanoma

ArticleYear
Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 07-28, Volume: 306

    Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Delivery Systems; Female; Fluorocarbons; Immunotherapy; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Oligopeptides; Phototherapy; Programmed Cell Death 1 Receptor; Tumor Microenvironment

2019
Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression.
    Clinical & experimental metastasis, 1993, Volume: 11, Issue:3

    Topics: Animals; Cell Adhesion; Down-Regulation; Endothelium, Vascular; Interleukin-1; Linoleic Acids; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Oligopeptides; Receptors, Cytoadhesin; Receptors, Vitronectin; Recombinant Proteins

1993
Organ-specific adhesion of neuroblastoma cells in vitro: correlation with their hepatic metastasis potential.
    Journal of pediatric surgery, 1997, Volume: 32, Issue:4

    Topics: Animals; beta-Galactosidase; Cell Adhesion; Extracellular Matrix Proteins; Female; Fibronectins; Kidney; Liver; Liver Neoplasms; Lung; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neuraminidase; Neuroblastoma; Oligopeptides; Organ Specificity; Spleen; Transplantation, Isogeneic; Tumor Cells, Cultured; Tunicamycin; Vitronectin

1997
Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
    The Journal of clinical investigation, 1988, Volume: 81, Issue:3

    Topics: Animals; Antineoplastic Agents; Blood Platelets; Cell Adhesion; Cell Communication; Killer Cells, Natural; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplastic Cells, Circulating; Oligopeptides; Tumor Cells, Cultured

1988